Abstract Elimination of endemic measles transmission is the culmination of a range of control measures at a national level. Current documentation of elimination proposed by WHO's regional offices requires achieving specific targets for surveillance process indicators. We demonstrate how Australia, although not meeting these specific targets, has satisfied multiple criteria that justify the formal declaration of measles elimination. Our review shows that few countries previously declaring measles elimination have satisfied the current WHO surveillance targets. We argue that the requirements for recognition of measles elimination should not restrict countries to a particular type of surveillance system or surveillance criteria.
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Une traduction en français de ce résumé figure à la fin de l'article. Al final del artículo se facilita una traducción al español. 
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Defining elimination
Several WHO regions have set target dates for the elimination of the transmission of endemic measles. The WHO Regional Office for the Western Pacific (WPRO) has nominated the target date of 2012. 1 Since measles elimination was first proposed, definitions of elimination have progressed from requiring a reduction to zero in the incidence of infection in a defined geographical area, 2 to the absence of endemic measles transmission and the lack of sustained transmission following an importation of measles virus in a large and well populated geographical area, as outlined in guidelines by WPRO. 3 The indicators adopted by WPRO to monitor the progress towards measles elimination provide an operational definition of measles elimination. 3, 4 Papania & Orenstein have argued that elimination can be declared if multiple lines of evidence demonstrate the absence of endemic measles transmission. 5 Several countries have declared elimination of endemic measles transmission using criteria that have become more rigorous over time (summarized in Table 1 , available at: http://www.who.int/bulletin/ volumes/87/1/07-046375/en/index.html), including the criteria we use here to declare elimination in Australia. As with other countries that have declared elimination of measles, Australia's national elimination plan included high two-dose immunization coverage and a disease surveillance system capable of a rapid response to potential measles outbreaks. 16 Australia, like many other countries that have declared elimination, would have difficulty meeting the WPRO elimination criteria based on currently available reporting of the investigation of presumptive measles cases (Table 2, available at: http://www.who.int/bulletin/volumes/87/1/07-046375/en/ index.html). However we believe multiple lines of evidence conclusively demonstrate the elimination of endemic measles transmission from Australia since 2005 at the latest, when notified confirmed cases were < 1 per million population. In this paper we outline how these criteria have been met, compare them with the WPRO criteria and justify their validity. We argue that a broader range of internationally accepted criteria for measles elimination is warranted.
Evidence of elimination Low incidence
Notifications of measles cases in Australia were sporadic until the establishment of the National Notifiable Diseases Surveillance System (NNDSS) in 1991. 17 Since then, public health legislation in all jurisdictions has included the mandatory reporting of measles cases by laboratories, clinicians and hospitals, to state and territory health departments. Notifications of confirmed cases are forwarded to the NNDSS. Since 2004, all Australian states and territories have adopted a case definition for a confirmed case of measles that requires laboratory evidence from an approved reference laboratory or an epidemiological link to a laboratory-confirmed case in conjunction with clinical evidence.
18 These improvements mean that all confirmed measles cases notified to the NNDSS since 2004 are likely to represent true cases (WPRO criterion 1, Table 2 ).
Since a large national outbreak in 1993-4 (Box 1), there has been a progressive downward trend in measles notifications. The 10 confirmed cases of measles in 2005 (0.5 cases per million population) was the lowest annual figure ever reported on the NNDSS (Fig. 1) . 24 A total of 125 cases were reported in 2006 (6 cases per million). 24 However, a large proportion (~54%) was attributable to a nationwide outbreak linked to the tour of a foreign spiritual group. Attendees at tour meetings were disproportionately opposed to vaccination and transmission was predominantly confined to one generation. 25, 26 In 2007, 11 cases were reported to the NNDSS (0.5 cases per million 24 ). In both 2005 and 2007, Australia met the WPRO target of 1 case per million population but not in 2006, a year in which we believe that endemic measles transmission did not occur in Australia.
Quality surveillance
Local public health authorities are responsible for the active follow-up of all suspected cases of measles (defined as morbilliform rash with fever present at onset of rash and cough) 27 to confirm the diagnosis and identify any additional cases. However, information about the investigation of suspected cases found not to be measles is not recorded at the national level, including laboratory performance indicators. Thus, due to reporting mechanisms, Australia is unable to provide data on the WPRO surveillance process criteria 3-7 ( showed that 89% of suspected cases could be discarded after laboratory investigation, at a median annual rate of 2.9/100 000. 29 This experience is likely to be applicable nationally and meets WPRO criterion 2.
High two-dose vaccine coverage
High vaccination coverage (greater than 95% for each new birth cohort) is required for herd immunity against measles and maintenance of measles elimination (WPRO criterion 8, Table 2). 30 Since 1998, Australia's measles elimination strategy has included vaccination coverage targets set to achieve 95% coverage with the first dose of measles-containing vaccine (MCV1) for children by 24 months and 90% two-dose (MCV2) coverage by school entry.
31 In 1989, a child health survey indicated coverage with at least one dose of a measles-containing vaccine Measles mortality decreases following the introduction of measles immunization, but there is ongoing transmission of a single endemic genotype (often as multiple strains of the same genotype).
21,22
Phase 2: measles control The incidence of measles and strain variation of the endemic genotype decline with expansion of immunization and outbreak control activities, 21 but susceptible individuals accumulate and large outbreaks occur after longer inter-epidemic periods. 1993-1994: large epidemic with > 10 000 notified cases 1993: second dose of measles-containing vaccine (measles-mumps-rubella, MMR) for all 10-16 year olds recommended, 19 prompted by large epidemic > 10 000 notified cases Although this led to an overall reduction in measles cases, outbreaks continued in school-aged children and young adults.
22
Phase 3: elimination Progression into the elimination phase facilitated by the Australian Measles Control Campaign, in which 1.33 million children (96% of the target age group) were vaccinated. The ACIR is estimated to capture more than 99% of Australian children aged less than 7 years. 33, 34 Coverage is reported for MCV1 at 2 years and 3 months of age and MCV2 at 6 years and 3 months of age to allow for delayed notification. In 2006, the ACIR recorded that 93.7-94.0% of children aged 2 years (born in 2004) had received at least one dose of MCV and 85.0-88.8% of children aged 6 years (born in 2000) had received both doses (Fig. 2) . Substantial geographic homogeneity was demonstrated with coverage of one dose ranging from 92.7-96.2% and coverage of two doses ranging from 85.6-90.2% across all states and territories. These are minimum estimates, with parental recall surveys suggesting that the ACIR underestimates coverage for MCV2 by 5-10% 33 and for vaccines scheduled at 12, 18 and 24 months of age by 3-5%. 34 When corrected for estimated underreporting, the national and WPRO target of 95% coverage for one dose of measles-containing vaccine is exceeded; coverage with a second dose is likely to be > 90%.
Outbreaks
The available surveillance data for Australia confirms that a high proportion
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Absence of an endemic genotype
Variability in the nucleotide sequence of the measles virus, of which there are eight clades (A-H) and 23 currently assigned genotypes (A, B1-B3, C1, C2, D1-D10, E, F, G1-G3, H1, H2), can be exploited for molecular epidemiological purposes.
37,38 Molecular analysis in routine case and outbreak investigations during the elimination phase of measles control is critical to document the genotype of each new cluster and demonstrate the absence of sustained transmission of one genotype (WPRO criterion 10, Table 2 ), to identify the source of the measles virus in outbreak situations and to confirm vaccine-associated fever/ rash illness (genotype A), which can also assist outbreak investigations. The D1 genotype was identified in the earliest samples available for analysis suggesting that genotype D1 may have been the endemic genotype in Australia in the prevaccine era. By 1985 the D7 genotype appeared to replace D1 as the endemic genotype. In the early 1990s, outbreaks of genotypes C2 and H1 were subsequently identified suggesting Australia had moved to the WHO-defined measles control phase of genotypic replacement. Since this time several genotypes have been identified, but none repeatedly, suggesting there have been no endemic genotypes in circulation since this time. (Fig. 5) . 42 More than 97% of people born before 1968, when measles vaccine first became available in Australia, had evidence of measles immunity.
Population immunity
43
Evidence from this source is robust as the serosurveys all used the same methods and demonstrated comparable results to prospectively collected, random-cluster sampling of school-age groups. 43, 44 We therefore believe that Australia's national serosurveys are an accurate measure of population level measles immunity. In 2002, population immunity was well above 90%.
Estimation of R
In disease modelling, infectious disease elimination is defined as the maintenance of the reproductive number, R below unity (R < 1). 45 The reproductive number, R, summarizes the susceptibility of the population, its mixing patterns and the contagiousness of the disease, and represents the average number of secondary cases produced by a typical case.
5,45 When R is > 1, the number of cases increase from one generation to the next and an epidemic ensues. When R is < 1, case numbers decrease from one generation to the next. If R is maintained constantly < 1 (the epidemic threshold), endemic transmission is considered to be eliminated. Using this definition, transmission of infective agents can still occur
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Measles elimination in Australiafollowing elimination but endemic transmission is not re-established at a population level. 46 Therefore, calculating R is a useful tool for monitoring the progress of elimination efforts. Estimates of R in the Australian setting have been obtained using several different methods with consistent results. 35, 36, 42, 47 The most robust method of calculating R is to use serosurveillance data to estimate susceptibility in each age group. 45 Using data from the 1996-1998 Australian national serosurvey (before the catch-up campaign), R was estimated as 0.90. 47 Since then, estimates of R using serological data have been well below the epidemic threshold; R was estimated as 0.57 from the 1999 serosurvey, and 0.69 in 2002, and modelled to remain below 0.8 until at least 2012. 42, 47 These estimates from serological data provide evidence that sustained transmission is unlikely to have occurred since 1999.
Besides using serosurveillance data, R can be estimated using enhanced disease notification data. There are three such methods. The first method uses the proportion of all cases that are identified as imported. 48 As the recording of whether a measles case is imported is incomplete on the NNDSS database, this method is likely to overestimate R. The two other methods of calculating R rely on data for the distribution of the size and duration of outbreaks. 46, 49 Using outbreak data from enhanced surveillance in Victoria between 1998 and mid-2003, R was calculated to be 0.85-0.87 using the size of outbreak method and 0.73-0.76 using data on the duration of outbreaks. 35 The similarity of the estimates of R using serosurveillance data to these estimates from case surveillance data (national and state estimates) supports the reliability of these estimates.
Discussion
The criteria used to justify our declaration of measles elimination in Australia are as follows: 1998-00 1993-97 1987-92 1985-86 1983-84 1978-82 1973-77 1968-72 (1) Based on the number of notified cases, the most conservative year for declaration of elimination in Australia is 2005, although multiple lines of evidence suggest interruption of the endemic transmission of measles since 1999. The set of interim criteria defined by WPRO for the documentation of elimination of endemic measles transmission in a region may not be practical in many countries such as Australia, despite the existence of adequate surveillance systems, due to varying capacity in reporting these criteria at a national level. This particularly applies to the extensive documentation on the investigation of suspected cases at national level, which currently includes the discard rate, laboratory performance indicators and obtaining virologic samples from every presumptive chain of transmission (WPRO criteria 2-7, Table 2 ). Australia satisfied the WPRO criterion of < 1 case per million population in 2005 and 2007. Although very low incidence is a significant criterion in defining measles elimination, we believe incidence rates > 1 case per million should not exclude declaration of elimination, especially if the cases are acquired outside the country and if other evidence suggests that sustained transmission has not occurred.
Adequate disease surveillance is an important criterion for establishing and monitoring measles elimination. The completeness of reporting, the sensitivity of the surveillance system, the use of laboratory confirmation, adequate epidemiological investigation of suspected measles cases and adequate genotyping of outbreaks are all important surveillance performance indicators.
4 Although Australia's surveillance reporting mechanisms do not currently record the investigation of presumptive measles cases at the national level as required by the WPRO criteria, we believe that surveillance is adequate for investigation of isolated cases of measles. Enhanced surveillance in the state of Victoria between 1998 and 2003 demonstrated reporting of non-measles suspected cases much higher than the WPRO target discard rate.
29 However, higher rates of discard (i.e. more clinically suspected cases of measles) were reported during the period directly after notification of a case
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Elimination de la transmission endémique de la rougeole en Australie L'élimination de la transmission endémique de la rougeole est le point culminant d'une série de mesures de lutte contre cette maladie au niveau national. Pour attester de l'élimination de la rougeole, les Bureaux régionaux de l'OMS proposent actuellement que les indicateurs servant à la surveillance aient atteint des objectifs spécifiques. Nous démontrons comment l'Australie, bien que n'ayant pas atteint ces objectifs, a rempli plusieurs critères justifiant la déclaration formelle de l'élimination de la rougeole. Notre analyse montre que peu de pays ayant antérieurement déclaré la rougeole comme éliminée ont rempli les objectifs actuels en matière de surveillance de l'OMS. A notre avis, les exigences pour reconnaître l'élimination de la rougeole ne devraient pas imposer aux pays l'utilisation d'un type particulier de système ou de critère pour la surveillance.
Resumen
Eliminación de la transmisión endémica del sarampión en Australia La eliminación de la transmisión endémica del sarampión supone la culminación de toda una serie de medidas de control desplegadas a nivel nacional. La actual documentación sobre la eliminación propuesta por las oficinas regionales de la OMS requiere que se alcancen metas concretas para los indicadores del proceso de vigilancia. Explicamos aquí de qué manera Australia, si bien no ha alcanzado esas metas específicas, ha satisfecho muchos criterios que justifican la declaración oficial de eliminación del sarampión. Nuestro análisis muestra que, entre los países que han declarado haber eliminado esta enfermedad, son pocos los que han alcanzado las actuales metas de vigilancia de la OMS. Se argumenta que, entre los requisitos para el reconocimiento de la eliminación del sarampión, no se debe exigir a los países que apliquen sólo un sistema de vigilancia o unos criterios de vigilancia determinados.
compared to periods when no measles case had been reported. The discard rate may therefore be a useful criterion at the beginning of the elimination phase but, when measles is rare, other diseases may be more likely to be suspected clinically and measles testing may not be requested by clinicians.
Australia's national one-dose coverage of a measles-containing vaccine satisfies the WPRO criteria, while Australia's national two-dose coverage is likely to be > 90%. However, Australia has provided additional data from a series of serosurveys that demonstrate 90% of the Australian population is immune to measles, providing the opportunity to identify population groups in need of targeted programmes. Additionally, modelling seroprevalence and surveillance data provides further evidence of elimination, with the reproductive number being maintained < 1. Finally, comprehensive molecular analyses provide substantial evidence of the absence of an endemic measles virus in Australia.
The declaration of the elimination of endemic measles from a region is not static and requires commitment to maintaining coverage, surveillance and outbreak control. Although England and Wales declared endemic measles eliminated in 2003 (Table 1) , sustained transmission has recurred due to a reduction in vaccination rates, 50 highlighting the requirement of maintenance as fundamental in declaring the elimination of endemic measles.
Under strict application of the WPRO criteria for case investigation, Australia would find it difficult to demonstrate measles elimination, as would most other countries that have previously declared elimination. However, the Australian criteria for the elimination of the transmission of endemic measles satisfy and extend the other WPRO criteria and lack only the WPRO surveillance process criteria 2-7. We believe the data presented confirm measles elimination in Australia and point to the need to broaden the current criteria for elimination of endemic measles transmission. ■ 
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